Table: Kobayashi Pharmaceutical -2018 group results

Kobayashi Pharmaceutical

31/01/2019 06:00

Jan 31 (Reuters)- 
          Kobayashi Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2018    Dec 31, 2017   Dec 31, 2019     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            167.48          156.76         173.00                 
                 (+6.8 pct)                     (+3.3 pct)               
  Operating         26.29           22.93          27.30                 
                 (+14.7 pct)                    (+3.8 pct)               
  Recurring         27.37           24.19          27.90                 
                 (+13.2 pct)                    (+1.9 pct)               
  Net                                              19.00                 
                                                (+5.4 pct)               
  Net               18.02           15.86                                
                 (+13.6 pct)                                             
  EPS            228.05 yen      201.31 yen     240.29 yen               
  EPS Diluted    227.95 yen      201.03 yen                              
  Ann Div         66.00 yen       58.00 yen      68.00 yen               
  -Q2 Div         31.00 yen       28.00 yen      33.00 yen               
  -Q4 Div         35.00 yen       30.00 yen      35.00 yen               
  
  NOTE - Kobayashi Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T